نبذة مختصرة : Introduction: We evaluated the long-term outcomes of recurrent glomerulonephritis (RGN) using clinical, histopathological, and demographic predictors.
Methods: A retrospective cohort study of kidney transplant recipients (KTR) in two renal centers between 2005 and 2020. Clinical and native kidney histological data were analyzed. The risk factors and outcomes of each primary glomerulonephritis subtype were assessed using Cox methods.
Result: 336 recipients with primary glomerulonephritis were analyzed. RGN was diagnosed in 17%, 20%, 25%, and 13% of recipients with IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN) and membranoproliferative glomerulonephritis (MPGN), respectively. Median time to recurrence was shortest in FSGS (.6 years IQR .2-2.9) and longest in MN (6.3 years IQR 3.3-8.0) whereas time to graft loss after diagnosis was shortest in MPGN (.3 years IQR .1-1.7) and longest in IgAN (2.9 year IQR 1.3-4.3). Recipients with recurrent IgAN were likely to be younger, have higher proteinuria at diagnosis, receive living donor allografts, receive cyclosporine treatment, have a history of acute rejection, and have segmental sclerosis in native glomeruli. Younger age of the donors, higher proteinuria at diagnosis, alemtuzumab, proteinuria within the first 12 months, acute rejection, low baseline eGFR, mesangial proliferation, and IgG and IgA deposits were associated with FSGS recurrence. MPGN recurrence was predicted by lower BMI at transplantation, and crescentic native disease. Death-censored graft survival at 5-, 10-, and 15-years was 83%, 51%, and 29% in the RGN group and 95%, 93%, and 84%, respectively in the non-RGN group. Over 15 years, recipients with RGN are nine times more likely than those without RGN to lose their grafts, regardless of donor type, acute rejection, and baseline eGFR. Transplant recipients of related donor allograft were not more likely to have recurrent GN than non-related donors.
(© 2023 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.)
References: Chukwu CA, Middleton R, Kalra PA. Recurrent glomerulonephritis after renal transplantation. Curr Opin Nephrol Hypertens. 2020;29(6):636-644. doi:10.1097/MNH.0000000000000643.
Jiang SH, Kennard AL, Walters GD. Recurrent glomerulonephritis following renal transplantation and impact on graft survival - Europe PMC Article - Europe PMC. BMC Nephrol. 2018;19:344-355. Accessed October 28, 2019 10.1186/s12882-018-1135-7.
Salvadori M. Recurrence of primary glomerulonephritis after renal transplantation. Juniper Publishers; 2017. https://www.researchgate.net/publication/321797359.
Uffing A, Pérez-Sáez MJ, la Manna G, et al. A large, international study on post-transplant glomerular diseases: the TANGO project. BMC Nephrol. 2018;19(1):299-236. doi:10.1186/s12882-018-1025-z.
Park H, Park WY, Kang SS, et al. Clinical outcomes of kidney transplantation in patients with biopsy-proven glomerulonephritis. Transplant Proc. 2018;50(4):1009-1012. doi:10.1016/j.transproceed.2018.02.039.
Pippias M, Stel VS, Aresté-Fosalba N, et al. Long-term kidney transplant outcomes in primary glomerulonephritis: analysis from the ERA-EDTA registry. Transplantation. 2016;100(9):1955-1962. doi:10.1097/TP.0000000000000962.
Allen PJ, Chadban SJ, Craig JC, et al. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461-469. doi:10.1016/j.kint.2017.03.015.
Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103-109. doi:10.1056/NEJMoa013036.
Hariharan S, Peddi VR, Savin VJ, et al. Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Am J Kidney Dis. 1998;31(6):928-931. doi:10.1053/ajkd.1998.v31.pm9631835.
Lim WH, Shingde M, Wong G. Recurrent and de novo glomerulonephritis after kidney transplantation. Front Immunol. 2019;10:1944. doi:10.3389/fimmu.2019.01944.
Ponticelli C, Glassock RJ. A definition, modern classification, and global epidemiology of primary glomerulonephritis. In: Ponticelli C, Glassock RJ, eds. Treatment of primary glomerulonephritis. 3rd ed. Oxford University Press; 2019. doi:10.1093/med/9780198784081.001.0001.
Baker R, Andrews DP, Renal association clinical practice guideline on post-operative care of the kidney transplant recipient. doi:10.1159/000328074.
Halloran PF, Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351(26):2715-2729. doi: 10.1056/NEJMra033540.
Markowitz G, Glomerular disease: updated oxford classification of IgA nephropathy: a new MEST-C score. Published online 2017. doi:10.1038/nrneph.2017.67.
Hull KL, Adenwalla SF, Topham P, Graham-Brown MP. Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist. Clin Med. 2022;22(1):34-40. doi:10.7861/CLINMED.2021-0472.
NHS Blood and Transplant. Annual Activity Report. ODT Clinical annual Activity Report. Published 2022. Accessed February 20, 2023. https://www.odt.nhs.uk/statistics-and-reports/annual-activity-report/.
Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014-1021. doi:10.1016/J.KINT.2017.02.003.
Austin PC, Allignol A, Fine JP. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model. J Clin Epidemiol. 2017;83:75-84. doi:10.1016/J.JCLINEPI.2016.11.017.
Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503-1510. doi:10.1016/0895-4356(95)00048-8.
Glassock RJ, Feildman D, Reynolds ES, Dammin Gustave J, Merrill JP. Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore). 1968;47(5):411-453.
Grupper A, Cornell LD, Fervenza FC, Beck LH, Lorenz E, Cosio FG. Recurrent membranous nephropathy after kidney transplantation: treatment and long-term implications. Transplantation. 2016;100(12):2710-2716. doi:10.1097/TP.0000000000001056.
Gupta G, Fattah H, Ayalon R, et al. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation. Clin Transplant. 2016;30(4):461-469. doi:10.1111/ctr.12711.
Avasare RS, Rosenstiel PE, Zaky ZS, et al. Predicting post-transplant recurrence of IgA nephropathy: the importance of crescents. Am J Nephrol. 2017;45(2):99-106. doi:10.1159/000453081.
Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol. 2010;5(12):2363-2372. doi:10.2215/CJN.06720810.
Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69(3):504-511. doi:10.1038/sj.ki.5000084.
Hosoya M, Kawasaki Y, Maeda R, et al. Predictive factors for poor outcome in pediatric C3 glomerulonephritis. Fukushima J Med Sci. 2018;64(3):142-150.
Stack A, Campbell E, Saran R, Dorman T, Donohoe J. Prevalence and predictors of recurrent IgA nephropathy following renal transplantation. Ir J Med Sci. 2000;169(4):248-252.
Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP. Recurrent Nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. Transplantation. 1991;52:827-831.
Ingulli E, Tejani A. Incidence, treatment and outcome of recurrent focal segmental glomeruloschlerosis post transplantation in 42 allografts in children-a single-center experience. Transplantation. 1991;51(2):401-405.
Senggutuvan P, Cameron JS, Hartley RB, et al. Recurrence of focal segmental glomerulosclerosis in transplanted. Pediatr Nephrol. 1990;4:21-28.
Cheong H, Han HW, Park HW, et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2000;15(1):78-81. doi:10.1093/ndt/15.1.78.
Wuhl E, Fydryk J, Wiesel M, Mehls O, Schaefer F, Scharer K. Impact of recurrent nephrotic syndrome after renal transplantation in young patients. Pediatr Nephrol. 1998;12(7):529-533. doi:10.1007/s004670050499.
Kim SJ, Ha J, Jung IM, et al. Recurrent focal segmental glomerulosclerosis following renal transplantation in Korean pediatric patients. Pediatr Transplant. 2001;5(2):105-111. doi:10.1034/j.1399-3046.2001.005002105.x.
Couser WG. Pathogenesis of glomerular damage in glomerulonephritis non-inflammatory mechanisms of glomerular injury. Nephrol Dial Transplant. 1998;13(1):10-15. Suppl.
Messina M, Gallo E, Mella A, Pagani F, Biancone L. Update on the treatment of focal segmental glomerulosclerosis in renal transplantation. World J Transplant. 2016;6(1):54. doi:10.5500/WJT.V6.I1.54.
Delville M, Sigdel TK, Wei C, et al. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med. 2014;6(256). doi:10.1126/SCITRANSLMED.3008538/SUPPL_FILE/6-256RA136_TABLES_S1_AND_S2.ZIP.
O'meara Y, Green A, Carmody M, et al. Recurrent glomerulonephritis in renal transplants: fourteen years’ experience. Nephrol Dial Transplant. 1989;4:730-734. Accessed November 14, 2019. https://academic.oup.com/ndt/article-abstract/4/8/730/1806489.
Chailimpamontree W, Dmitrienko S, Li G, et al. Probability, predictors, and prognosis of posttransplantation glomerulonephritis. J Am Soc Nephrol. 2009;20(4):843-851. doi:10.1681/ASN.2008050454.
Yu TM, Wen MC, Wu MJ, et al. Impact of posttransplantation glomerulonephritis on long-term outcome of kidney transplants: single-center 20-year experience. World J Surg. 2012;36(12):2923-2930. doi:10.1007/s00268-012-1759-x.
Bachman U, Biava C, Amend W, et al. The clinical course of IgA nephropathy and Henoch-Schönlein purpura following renal transplantation. Transplantation. 1986;42(5):511-515.
Kennard AL, Jiang SH, Walters GD. Increased glomerulonephritis recurrence after living related donation. BMC Nephrol. 2017;18(1). doi:10.1186/s12882-016-0435-z.
Ortiz F, Gelpi R, Koskinen P, et al. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Transplant. 2012;27:2553-2558. doi:10.1093/ndt/gfr664.
McGrogan A, Franssen CFM, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):414-430. doi:10.1093/NDT/GFQ665.
Processing Request
No Comments.